When managing a patient with PDA, what medication should NOT be administered?

In the management of a patient with patent ductus arteriosus (PDA), certain medications can help close the ductus, while others would not be appropriate. Among the options, the use of Motrin (Ibuprofen), a nonsteroidal anti-inflammatory drug (NSAID), is commonly utilized due to its ability to inhibit prostaglandin synthesis, promoting the closure of the PDA.

On the contrary, prostaglandins are used to maintain the patency of the ductus in certain situations, such as in patients requiring adequate blood flow to vital organs, especially if they have congenital heart defects that rely on a patent ductus for systemic or pulmonary circulation. Aspirin may also be utilized in some cases, particularly for its antiplatelet effects in preventing thromboembolic events.

Furosemide, a diuretic, can be given to manage fluid overload and symptoms of heart failure related to PDA but does not directly affect the ductus arteriosus itself.

In summary, while other medications like Motrin can help close a PDA, the use of prostaglandins is essential in scenarios where maintaining ductal patency is critical. Therefore, understanding the role and effect of each medication is crucial in making informed